The stool syndecan2 methylation test is more robust than blood tests for methylated septin9, CEA, CA19-9 and CA724: a diagnostic test for the early detection of colorectal neoplasms

BACKGROUND: Methylated syndecan2 (mSDC2) in stool samples has been found to be associated with colorectal cancer (CRC) and precancerous lesions. However, the available data are limited, and no previous studies have compared the analysis of mSDC2 with other diagnostic tests. Thus, we aimed to evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Yixiang, Wang, Shuyuan, Yuan, Zhen, Zhao, Xuanzhu, Ni, Kemin, Xin, Ran, Zhou, Xingyu, Liu, Zhaoce, Yin, Xin, Ping, Hangyu, Liu, Yaohong, Wang, Wanting, Yan, Suying, Han, Qiurong, Zhang, Xipeng, Zhang, Qinghuai, Liu, Yandi, Zhang, Chunze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906059/
https://www.ncbi.nlm.nih.gov/pubmed/36760372
http://dx.doi.org/10.21037/tcr-22-1710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906059/
https://www.ncbi.nlm.nih.gov/pubmed/36760372
http://dx.doi.org/10.21037/tcr-22-1710

Ejemplares similares